Moxifloxacin Stulln Sine

Moxifloxacin, the active ingredient in Moxifloxacin Stulln Sine, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. It treats bacterial conjunctivitis, bacterial keratitis and other susceptible ocular bacterial infections.\n\nGNH India supplies Moxifloxacin Stulln Sine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibiotic used to manage bacterial infections of the eye.\n\nBacterial conjunctivitis: reduces bacterial load and resolves inflammation in the conjunctiva.\nBacterial keratitis: eradicates pathogenic bacteria in the cornea, promoting healing.\nOther susceptible ocular infections: targets a broad range of Gram‑negative and Gram‑positive organisms causing ocular disease.

Moxifloxacin may cause ocular and systemic adverse reactions.\n\nCommon Side Effects:\n- Burning or stinging sensation upon instillation.\n- Temporary blurred vision.\n- Redness of the conjunctiva.\n- Mild eye irritation or itching.\n- Tearing or discharge.\n\nSerious or Rare Side Effects:\n- Corneal ulceration or perforation.\n- Severe allergic reaction (e.g., angioedema, anaphylaxis).\n- Tendon rupture or tendonitis (systemic exposure).\n- Central nervous system effects such as seizures.\n- Phototoxic skin reactions.

Before using Moxifloxacin Stulln Sine, consider the following precautions.\n\nAllergy assessment: avoid if known hypersensitivity to fluoroquinolones.\nContact lens wearers: remove lenses before instillation and wait before reinserting.\nPregnancy and lactation: use only if clearly needed and prescribed.\nConcurrent ocular disease: monitor for worsening infection or inflammation.\nSystemic fluoroquinolone exposure: be aware of tendon and CNS risks.\nStore below 25°C: keep in original container, protect from moisture and light.

Moxifloxacin can interact with other medications and substances.\n\nMajor Interactions (Avoid):\n- Systemic fluoroquinolones: increased risk of tendon rupture.\n- Anticholinergic eye drops: may reduce ocular absorption.\n\nModerate Interactions (Monitor Closely):\n- Non‑steroidal anti‑inflammatory eye drops: potential additive irritation.\n- Corticosteroid eye preparations: may mask signs of infection.\n- Herbal supplements containing quinine: possible additive QT prolongation.